Population
1 patient with profuse cutaneous pigmented lesions, subcutaneous myxoid neurofibromata and atrial myxoma
Design
Case_report
Authors
Loading...
Cutaneous signs in NAME syndrome may prompt earlier myxoma evaluation; hypothesis-generating for screening protocols in this rare syndrome.
Recognition of distinctive cutaneous manifestations in NAME syndrome can lead to the early diagnosis and treatment of potentially lethal atrial myxomas.
Atherton et al. (1980) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: